Introducing a sepsis screening protocol with PCT as a standard parameter

Introducing a sepsis screening protocol with PCT as a standard parameter

In Hospital Universitario Doctor Peset, a large referral hospital in Valencia, Spain, the introduction of a sepsis screening protocol with procalcitonin (PCT) as a standard parameter has reduced mortality and ICU admissions.

In the Internal Medicine Unit alone, spending on antibiotics has been reduced by 30 %.

“The ease of use of the Radiometer AQT90 FLEX analyser has freed up resources in the department for other tasks. The analyser requires less space, fewer consumables, and very limited maintenance compared to other Procalcitonin measurement systems.

Furthermore, the device has built-in quality control procedures that detect immediate errors during each measurement and a system check for regularly monitoring the system status. This ensures that the analyser works accurately and precisely,” says Dr Nuria Estañ Capell, Head of the Clinical Analysis Department.

About the hospital

  • Universitario Doctor Peset, Spain

  • Clinical Analysis Department

Valencia is one of the most innovative laboratories in Spain.

Thanks to the Head of the Clinical Analysis Department, Dr Nuria Estañ Capell, pre-analytical, analytical and post-analytical processes have been incorporated in an automated chain, significantly improving response times.

The automation has also led to a reduction of routine stock and inventory tasks, freeing up resources for other tasks. 

The ease of use of the Radiometer AQT90 FLEX analyser has freed up resources in the department for other tasks. It requires less space, fewer consumables, and very limited maintenance compared to other Procalcitonin measurement systems.

- Dr Nuria Estañ Capell, Head of the Clinical Analysis Department

Nuria Estañ Capell, Head of the Clinical Analysis Department

Nuria Estañ Capell, Head of the Clinical Analysis Department


The AQT90 FLEX PCT assay

The AQT90 FLEX analyser played an important role in the reorganisation of the laboratory. With the AQT90 FLEX analyser, blood samples do not need to be handled after collection.

The previous processes could sometimes lead to pre-analytical errors with serious consequences to the patient and/or danger to the health of the operator due to the biological risk associated with handling blood samples.

The analyser can measure procalcitonin in 21 minutes, which makes it an effective tool in the early detection of sepsis and septic shock.

“We have taken part in a European study comparing the AQT90 FLEX analyser to the B·R·A·H·M·S® KRYPTOR®, which is considered the gold standard, and the system we had previously,” says Dr Estañ.

Although the two methods are comparable in terms of reliability, waiting time and cost, the Radiometer solution was the one chosen by Dr Estañ’s department.

“It is simpler, takes up much less space, uses very few consumables, and requires very little maintenance. Furthermore, the device has built-in quality control procedures that detect immediate errors during each measurement and a system check that regularly monitors the system status. This ensures that the analyser works accurately and precisely.”

The head of the department reckons that any member of the laboratory staff can easily use the AQT90 FLEX analyser by consulting the guide uploaded to the hospital intranet.

An additional deciding factor in selecting Radiometer was the reliability on local technical support. This means that breakdowns can be addressed quickly, thereby avoiding long downtime periods when the analyser is not available. This factor is extremely important for a hospital like Doctor Peset where “Code Sepsis,” a screening protocol for sepsis, has been implemented.

The sepsis screening protocol

The protocol was jointly agreed by various departments in 2012 for the early treatment of sepsis and includes, among other parameters, PCT as a standard screening test.

The Hospital Universitario Doctor Peset was the second in Spain to implement this system, which is monitored by the pioneering Hospital Son Llàtzer in Palma de Mallorca.

“It began in the emergency department and was eventually extended to the whole hospital. In our case, we have a nursing resource to coordinate the program,” explains Dr Estañ.

When there is a positive result for sepsis, an alarm is activated within the computerised system so that the patient can be given antibiotic treatment as a matter of urgency.

- Dr Nuria Estañ Capell, Head of Clinical Analysis Department

Results with implementation of “Code Sepsis”

During the first year after Code Sepsis was introduced, mortality and ICU admissions due to sepsis decreased, as well as the administration of unnecessary antibiotics, preventing the development of multi-resistant bacteria and hospital-acquired infections.

“At the University Hospital Doctor Peset, we have three daily admissions for sepsis, i.e. about 1,000 patients per year, and the mortality rate in 2012 was 24 % below the national average of 33 %. After the activation of the Code Sepsis, we have managed to reduce the mortality rate to 17 % in 2016.

The new approach has, unsurprisingly, also had an effect on the hospital’s costs. “In the Internal Medicine Unit alone, spending on antibiotics has been reduced by 30 %,” says Dr Estañ.

Note on trade marks

B·R·A·H·M·S PCT® and B·R·A·H·M·S® are registered trade marks of B·R·A·H·M·S GmbH; KRYPTOR® is a registered trade mark of Cisbio Bioassays; all other trade marks belong to their respective owners.

Cookies are used on this website

Use of cookies
Confirm your account with Radiometer

Please enter a valid email

CONTINUE
By submitting your e-mail you agree to the data policy notice
Radiometer is using Microsoft Azure Active Directory to authenticate customer access. If you are already registered you will be taken to Microsoft AD to sign in using your Microsoft AD credentials.
You are already registered
Radiometer is using Microsoft Azure AD to authenticate customer access. If you are already registered you will be taken to AZURE to sign in using your AZURE credentials.
Thank you

We will be sending an e-mail invitation to you shortly to sign in using Microsoft Azure AD.

Radiometer is using Microsoft Azure AD to authenticate customer access.
Sorry

It seems that your e-mail is not registered with us

Radiometer is using Microsoft Azure AD to authenticate customer access. If your e-mail is not registered with us please click CONTINUE and we will guide you through the sign-in process.
We have previously sent an invitation by e-mail

Please click "Get started" in the e-mail to complete the registration process

Radiometer is using Microsoft Azure AD to authenticate customer access.
Sorry

We were not able to process your request due to a communication error

Sorry

It seems this account has not been given access to the portal

Radiometer is using Microsoft AZURE Active Directory to authenticate users

Radiometer uses Azure AD to provide our customers and partners secure access to documents, resources, and other services on our customer portal.

If your organization is already using Azure AD you can use the same credentials to access Radiometer's customer portal.

Key benefits

       
  • Allow the use of existing Active Directory credentials
  •    
  • Single-sign on experience
  •    
  • Use same credentials to access future services    

Request access

You will receive an invitation to access our services via e-mail when your request  has been approved.

When you accept the invitation, and your organization is already using AZURE AD, you can use the same credentials to access Radiometer's customer portal. Otherwise, a one-time password will be sent via e-mail to sign in.

Effective Date January 20th, 2023 (last updated January 20th, 2023)

ABOUT THIS POLICY

Radiometer values your privacy and the protection of your personal data. This policy (“Policy”) explains how Radiometer its affiliates, subsidiaries or related companies, a full list of which can be located here (together, “Radiometer,”, “our”, “us,” or “we”), collects, uses, shares, transfers and processes data collected from or about you.

Personal Data” is any information that can be used to directly or indirectly identify an individual or that can be reasonably expected to link to an individual. This can include items such as name, address, telephone number, credit card details, email address, ID number, Internet Protocol (“IP”) address of an electronic device used by an individual, or other identifying code (even absent of other identifying information). Statistical and non-identifiable metric data are not considered Personal Data.

The Radiometer subsidiary, affiliate or related company with which you interact is, where applicable, the data controller (or equivalent under applicable law) responsible for the processing of your Personal Data. You can find a list of the relevant legal entities that act as data controllers in Appendix 1 to this Policy.

SCOPE

This Policy describes the types of Personal Data that we may collect, process or disclose about you and how you may govern this processing by exercising applicable legal rights. This Policy applies to both online and offline information collection, including your use of websites or subdomains operated by us, any mobile applications, when we provide products and/or services to you or notify you about prospective items of interest and in other situations where you interact with us in-person, by telephone or by mail where this Policy is posted or referenced.

There may be occasion where you have been provided with a circumstance-specific privacy notice that is separate from this policy, such as privacy notices for specific activities such as Recruitment. To the extent you were provided with a different notice, those notices apply and govern our interactions with you. If you provide Personal Data about parties other than yourself, you are responsible for ensuring their knowledge of how we will process their personal data, and, where applicable, obtaining any necessary consents required in advance.

Read more